|Articles|March 1, 2009
Insulin pens and the blind
Recently, several manufacturers of insulin pens for diabetes treatment have added warnings to the devices, cautioning against their use by visually impaired patients.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
IGS 2026: Navigating MIGS and other modern glaucoma procedures
2
IGS 2026: Clinical pearls for detecting pre-perimetric glaucoma
3
IGS 2026: The expanding role of artificial intelligence in ophthalmology
4
IGS 2026: Current clinical perspectives on optic disc drusen
5
























